Previous 10 | Next 10 |
2024-02-12 08:41:44 ET More on Novo Nordisk Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Booming weight-loss drug market to lift “pick-and-shovel...
2024-02-09 13:39:14 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent Q2 2024 Earnings Preview EU drug regulators to assess potenti...
2024-02-09 13:21:35 ET More on AstraZeneca AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss AstraZeneca PLC 2023 Q4 - Results - Earnings Call Presentation Ionis-AstraZeneca amyl...
2024-02-09 08:02:43 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent Q2 2024 Earnings Preview EU drug regulators to assess potenti...
Q2'24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency (1) , compared to Q2'23. Q2'24 net revenue, excluding COVID-related revenue of ~$260 million in Q2’23 and ~$75 million in Q2’24, increased 8% compared to Q2'23. ...
Asics Corporation ADR (ASCCY) is expected to report for quarter end 2023-12-31 W. P. Carey Inc. REIT (WPC) is expected to report $1.16 for Q4 2023 Core Scientific, Inc. (CORZQ) is expected to report for Q4 2023 Essent Group Ltd. (ESNT) is expected to report $1.59 for Q4 2023 SAAB ...
2024-02-08 11:38:41 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript EU drug regulators to assess potential impact of Catalent-Novo merger ...
2024-02-07 17:43:49 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent ticks lower amid report Indiana plant may have quality issues ...
2024-02-07 16:29:17 ET Summary We anticipate an FTC review for the Novo Holdings acquisition of Catalent, Inc. but see no grounds for blocking. Timetable risk due to regulatory approval under HSR Act. Attractive 10.2% gross spread with favourable probability of closing. ...
2024-02-07 13:43:49 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...
News, Short Squeeze, Breakout and More Instantly...
Expansion adds more temperature-controlled storage and dedicated space for FastChain ® demand-led supply service Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansio...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...